Aoife Brennan
President and CEO · Climb Bio, Inc.
- 2025
- Jun 30, 2026
- 4
Summary
Latest filing:
Aoife Brennan is President and CEO of Climb Bio, Inc. (CLYM). 4 SEC Form 4 filings on record going back to 2025, most recently on 30 June 2026. Most recent open-market trade: sold $407K of CLYM on 30 June 2026. Lifetime open-market sales: $432K.
Recent transactions
4The latest 4 SEC Form 4 transactions reported by Aoife Brennan.
Trading pattern
InsiderAlpha's records for Aoife Brennan go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. 3 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Aoife Brennan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Stephen Basil Thomas - $2.25M in CLYM purchases and sales in the last 12 months
- GILEAD SCIENCES, INC. - $2.00M in XLO purchases and sales in the last 12 months
- James Samuel Shannon - $44K in XLO purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $25K in CLYM purchases and sales in the last 12 months
- Christopher James Frankenfield - $5K in XLO purchases and sales in the last 12 months
- Kevin M. Brennan - $1K in XLO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Aoife Brennan?
Aoife Brennan is a corporate insider, tracked as President and CEO of Climb Bio, Inc. (CLYM). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Aoife Brennan last file a Form 4?
The most recent primary Form 4 on record is dated 30 June 2026, one of 4 filings going back to 2025.
Has Aoife Brennan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($432K) across all tracked filings.